PALLANTE, PIERLORENZO
 Distribuzione geografica
Continente #
AS - Asia 1.497
NA - Nord America 1.244
EU - Europa 442
SA - Sud America 326
Continente sconosciuto - Info sul continente non disponibili 82
AF - Africa 29
OC - Oceania 1
Totale 3.621
Nazione #
US - Stati Uniti d'America 1.188
SG - Singapore 676
CN - Cina 275
BR - Brasile 248
VN - Vietnam 189
HK - Hong Kong 174
IT - Italia 136
NL - Olanda 98
FR - Francia 88
KR - Corea 41
CA - Canada 33
GB - Regno Unito 31
BD - Bangladesh 30
AR - Argentina 27
DE - Germania 27
JP - Giappone 25
IN - India 15
ID - Indonesia 14
EC - Ecuador 13
VE - Venezuela 11
FI - Finlandia 10
CO - Colombia 9
ES - Italia 9
MX - Messico 9
ZA - Sudafrica 8
IL - Israele 7
PL - Polonia 7
PY - Paraguay 6
SA - Arabia Saudita 6
IQ - Iraq 5
KE - Kenya 5
MA - Marocco 5
PH - Filippine 5
UY - Uruguay 5
LT - Lituania 4
PK - Pakistan 4
SE - Svezia 4
SV - El Salvador 4
TR - Turchia 4
UA - Ucraina 4
AL - Albania 3
JM - Giamaica 3
JO - Giordania 3
KZ - Kazakistan 3
MY - Malesia 3
PE - Perù 3
RU - Federazione Russa 3
TN - Tunisia 3
UZ - Uzbekistan 3
BO - Bolivia 2
CL - Cile 2
DO - Repubblica Dominicana 2
EE - Estonia 2
EG - Egitto 2
GR - Grecia 2
IE - Irlanda 2
LV - Lettonia 2
SC - Seychelles 2
TH - Thailandia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
CH - Svizzera 1
CR - Costa Rica 1
CV - Capo Verde 1
CY - Cipro 1
ET - Etiopia 1
GD - Grenada 1
HN - Honduras 1
IR - Iran 1
IS - Islanda 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
MK - Macedonia 1
MU - Mauritius 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
PS - Palestinian Territory 1
PT - Portogallo 1
RE - Reunion 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.540
Città #
Singapore 384
Santa Clara 222
Hong Kong 173
San Jose 168
Ashburn 112
Lauterbourg 74
Beijing 69
Hefei 59
Ho Chi Minh City 58
Hanoi 50
Seoul 41
Los Angeles 35
Naples 24
Tokyo 21
New York 19
Rome 19
Dallas 18
São Paulo 18
Buffalo 13
Council Bluffs 13
Chicago 12
Frankfurt am Main 12
Milan 11
Orem 11
Brooklyn 10
Da Nang 10
Rio de Janeiro 10
Houston 9
Atlanta 8
Brasília 8
Helsinki 8
Toronto 8
Falkenstein 7
Portsmouth 7
Warsaw 7
Amsterdam 6
Bắc Giang 6
Haiphong 6
London 6
Quito 6
Biên Hòa 5
Charlotte 5
Düsseldorf 5
Manchester 5
Nairobi 5
Orlando 5
Philadelphia 5
Porto Alegre 5
Vũng Tàu 5
Baltimore 4
Chennai 4
Curitiba 4
Feira de Santana 4
Genoa 4
Jakarta 4
Medellín 4
Paris 4
Phoenix 4
Piscataway 4
Plano 4
Princeton 4
Prineville 4
Quảng Ngãi 4
Quận Bình Thạnh 4
San Salvador 4
Stockholm 4
Tel Aviv 4
The Bronx 4
Acalanes Ridge 3
Amman 3
Asunción 3
Belo Horizonte 3
Blumenau 3
Boston 3
Bắc Ninh 3
Campinas 3
Caserta 3
Caxias do Sul 3
Cincinnati 3
Detroit 3
Dhaka 3
Durban 3
Formia 3
Fort Wayne 3
Jeddah 3
Kingston 3
Kuala Lumpur 3
Lanham 3
Las Vegas 3
League City 3
Lodi 3
Madrid 3
Mauá 3
Miami 3
Minamishinagawa 3
Montevideo 3
Montreal 3
Nam Định 3
Quận Một 3
Recife 3
Totale 1.975
Nome #
CBX7 gene expression plays a negative role in adipocyte cell growth and differentiation. 85
Differential Expression of LncRNA in Bladder Cancer Development 83
PATZ1 acts as a tumor suppressor in thyroid cancer via targeting p53-dependent genes involved in EMT and cell migration 76
Development and validation of a prognostic model based on RNA binding proteins in patients with esophageal cancer 74
Liquid Biopsy Is a Promising Tool for Genetic Testing in Idiopathic Pulmonary Fibrosis 68
Long non-coding RNAs regulating multiple proliferative pathways in cancer cell 67
A differential proteomic approach to identify proteins associated with thyroid cell transformation 66
UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas. 66
Setting up and exploitation of a nano/technological platform for the evaluation of HMGA1b protein in peripheral blood of cancer patients. 62
The role of HMGA1 protein in gastroenteropancreatic neuroendocrine tumors 61
Oncogenic Properties of the Antisense lncRNA COMET in BRAF- and RET-Driven Papillary Thyroid Carcinomas 61
Microsatellite instability evaluation of patients with solid tumour: routine practice insight from a large series of Italian referral centre 61
Deregulation of microRNA expression in follicular cell-derived human thyroid carcinomas 60
CDH-16 Gene expression in thyroid cell differentiation and trasformation 60
The metallophosphoesterase-domain-containing protein 2 (MPPED2) gene acts as tumor suppressor in breast cancer 60
Phosphoprotein enriched in diabetes (PED/PEA15) promotes migration in hepatocellular carcinoma and confers resistance to sorafenib 59
Setting up and exploitation of a nano/technological platform for the evaluation of HMGA1b protein in peripheral blood of cancer patients. Nanomedicine. 57
Tumour Suppressor Role of the CL2/DRO1/CCDC80 Gene in Thyroid Carcinogenesis. 56
Drug-induced inhibition of HMGA and EZH2 activity as a possible therapy for anaplastic thyroid carcinoma 55
The lncRNA RMST is drastically downregulated in anaplastic thyroid carcinomas where exerts a tumor suppressor activity impairing epithelial-mesenchymal transition and stemness 55
MPPED2 is downregulated in glioblastoma, and its restoration inhibits proliferation and increases the sensitivity to temozolomide of glioblastoma cells 55
UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients 53
The cl2/dro1/ccdc80 null mice develop thyroid and ovarian neoplasias 51
BRCA1/2 NGS Somatic Testing in Clinical Practice: A Short Report 50
Restoration of CBX7 expression increases the susceptibility of human lung carcinoma cells to irinotecan treatment 50
The long non-coding RNA RP5-1024C24.1 and its associated-gene MPPED2 are down-regulated in human thyroid neoplasias and act as tumour suppressors 49
The control of tumor progression by circular RNAs: novel prognostic and therapeutic insights resulting from the analysis of the circAGO2/human antigen R complex 49
MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle 49
Noncoding RNAs in Thyroid-Follicular-Cell-Derived Carcinomas 49
Structural Model of the hUbA1-UbcH10 Quaternary Complex: In Silico and Experimental Analysis of the Protein-Protein Interactions between E1, E2 and Ubiquitin. 48
The long non-coding RNA prader willi/angelman region RNA5 (PAR5) is downregulated in anaplastic thyroid carcinomas where it acts as a tumor suppressor by reducing EZH2 activity 47
Deregulation of microRNA expression in thyroid neoplasias 46
HMGA1 Expression in Human Hepatocellular Carcinoma Correlates with Poor Prognosis and Promotes Tumor Growth and Migration in in vitro Models. 46
Let-7a Down-Regulation Plays a Role in Thyroid Neoplasias of Follicular Histotype Affecting Cell Adhesion and Migration through Its Ability to Target the FXYD5 (Dysadherin) Gene 46
CBX7 Modulates the Expression of Genes Critical for Cancer Progression 46
KRAS Mutant Allele-Specific Imbalance (MASI) assessment in routine samples of patients with metastatic colorectal cancer. 45
Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cells. 45
The "next-generation" knowledge of papillary thyroid carcinoma 45
Chromobox protein homologue 7 protein, with decreased expression in human carcinomas, positively regulates E-cadherin expression by interacting with the histone deacetylase 2 protein. 44
High mobility group A-interacting proteins in cancer: focus on chromobox protein homolog 7, homeodomain interacting protein kinase 2 and PATZ 42
High expression of HOXA13 correlates with poorly differentiated hepatocellular carcinomas and modulates sorafenib response in in vitro models 42
HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity. 41
Circulating Tumour Cells in Predictive Molecular Pathology: Focus on Drug-Sensitive Assays and 3D Culture 41
High mobility group a proteins as tumor markers. 40
New somatic mutations and WNK1-B4GALNT3 gene fusion in papillary thyroid carcinoma. 40
CBX7 Expression in Oncocytic Thyroid Neoplastic Lesions (Hurthle Cell Adenomas and Carcinomas). 40
Polycomb protein family member CBX7 plays a critical role in cancer progression 38
Loss of the CBX7 gene expression correlates with a highly malignant phenotype in thyroid cancer. 38
HMGA1 overexpression is associated with a particular subset of human breast carcinomas 37
miR-191 Down-Regulation Plays a Role in Thyroid Follicular Tumors through CDK6 Targeting 35
Oestrogens and selective oestrogen receptor (ER) modulators regulate EGF receptor gene expression through human ER alpha and beta subtypes via an Sp1 site 35
Harmonization trial of FGFR1-3 testing strategies in cholangiocarcinoma patients: an Italian multicenter experience 33
Editorial: Second Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological and Molecular Aspects of Novel Promising Drugs 33
HMGA1 and HMGA2 protein expression correlates with advanced tumour grade and lymph node metastasis in pancreatic adenocarcinoma 33
The Interconnection Between UbcH10, p53, and EGFR in Lung Cancer Cells and Their Involvement in Treatment Response 32
CBX7 and HMGA1b proteins act in opposite way on the regulation of the SPP1 gene expression 32
Suppression of HMGA2 protein synthesis could be a tool for the therapy of well differentiated liposarcomas overexpressing HMGA2 32
Ion Torrent next-generation sequencing for routine identification of clinically relevant mutations in colorectal cancer patients 32
UbcH10 overexpression in human lung carcinomas and its correlation with EGFR and p53 mutational status 32
Harmonization trial on ESR1 testing strategies in ER+/HER2- breast cancer patients: an Italian experience 31
Genome-wide profiling of a prognostic RNA-binding protein signature in esophageal cancer 31
High mobility group A1 enhances tumorigenicity of human cholangiocarcinoma and confers resistance to therapy. 31
UbcH10 Expression on Thyroid Fine-Needle Aspirates 30
Epigenetic modifications induced by Helicobacter pylori infection through a direct microbe-gastric epithelial cells cross-talk 29
The tyrosine phosphatase PTPRJ/DEP-1 genotype affects thyroid carcinogenesis 29
Down-Regulation of the miR-25 and miR-30d Contributes to the Development of Anaplastic Thyroid Carcinoma Targeting the Polycomb Protein EZH2 29
CBX7 is a tumor suppressor in mice and humans (vol 122, pg 612, 2012) 28
UbcH10 expression in human lymphomas. (vol 54, pg 731, 2009) 28
High mobility group A1 expression correlates with the histological grade of human glial tumors 27
Noninvasive Biomarkers of Colorectal Cancer: Role in Diagnosis and Personalised Treatment Perspectives 27
Identification of a prognostic DNA repair gene signature in esophageal cancer 27
A TSH-CREB1-microRNA Loop Is Required for Thyroid Cell Growth 26
Performance of EGFR mutant-specific antibodies in different cytological preparations: A validation study 26
Thyrotropin Regulates Thyroid Cell Proliferation by Up-Regulating miR-23b and miR-29b that Target SMAD3 26
CDH16/Ksp-cadherin is expressed in the developing thyroid gland and is strongly down-regulated in thyroid carcinomas. 25
New somatic mutations and WNK1-B4GALNT3 gene fusion in papillary thyroid carcinoma 24
Novel biomarkers of fibrosis in Crohn's disease. 24
MiR-1 Is a Tumor Suppressor in Thyroid Carcinogenesis Targeting CCND2, CXCR4, and SDF-1 alpha 23
EGFR mutation detection by microfluidic technology: a validation study 22
UbcH10 overexpression is less pronounced in older colorectal cancer patients 22
Tumor suppressor activity of CBX7 in lung carcinogenesis 22
Tumor Suppressor Role of the CL2/DRO1/CCDC80 Gene in Thyroid Carcinogenesis 22
The "next-generation" knowledge of papillary thyroid carcinoma. 21
Role of PTPRJ genotype in papillary thyroid carcinoma risk 21
Transcriptional profile of Ki-Ras-induced transformation of thyroid cells 21
HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias 16
Totale 3.621
Categoria #
all - tutte 13.369
article - articoli 13.190
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.559


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202434 0 0 0 0 0 0 0 0 2 0 26 6
2024/20251.212 15 6 107 48 189 60 26 87 49 115 275 235
2025/20261.848 61 109 148 259 380 76 293 106 118 129 80 89
2026/2027527 152 92 283 0 0 0 0 0 0 0 0 0
Totale 3.621